Alaunos Therapeutics, Inc. (TCRT)
USD 2.53
(12.95%)
USD 2.53
(12.95%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -30.14 Million | -29.23 Million | -61.46 Million | -57.01 Million | -40.85 Million | -49.45 Million |
| Net Income | -35.14 Million | -37.73 Million | -78.75 Million | -79.97 Million | -117.79 Million | -53.11 Million |
| Depreciation & Amortization | 2.31 Million | 2.75 Million | 2.59 Million | 1.12 Million | 629 Thousand | 575 Thousand |
| Deferred income taxes | 770 Thousand | - | 740 Thousand | -10.36 Million | - | - |
| Stock-based compensation | 2.8 Million | 3.52 Million | 10.77 Million | 6.82 Million | 7.34 Million | 7.53 Million |
| Change in working capital | -6.25 Million | -1.06 Million | 2.78 Million | 15 Million | 8.22 Million | -4.29 Million |
| Other non-cash items | 5.36 Million | 3.27 Million | 383 Thousand | 10.36 Million | 60.75 Million | -158 Thousand |
| Investing Cash Flow | 1.34 Million | -193 Thousand | -3.32 Million | -9.77 Million | -284 Thousand | -459 Thousand |
| Investments in PPE | -197 Thousand | -216 Thousand | -3.32 Million | -9.77 Million | -284 Thousand | -459 Thousand |
| Acquisitions | 1.54 Million | 23 Thousand | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 1.54 Million | 23 Thousand | - | -9.77 Million | - | - |
| Financing Cash Flow | -18.13 Million | 6.36 Million | 25.77 Million | 102.11 Million | 59.15 Million | 40.31 Million |
| Debt repayment | -18.1 Million | -8.33 Million | -24.74 Million | - | - | -17.23 Million |
| Dividends payments | - | - | - | - | - | -16.99 Million |
| Common Stock Repurchased | - | -45 Thousand | - | - | -653 Thousand | -1.62 Million |
| Common Stock Issuance | 92 Thousand | 14.72 Million | 1.03 Million | 101.67 Million | 6.08 Million | 47.1 Million |
| Other Financing Activities | -125 Thousand | 21 Thousand | 49.48 Million | 442 Thousand | 53.71 Million | 29.06 Million |
| Accounts receivables | 3000.00 | 1.1 Million | 3.55 Million | -1.33 Million | -1.46 Million | -1.84 Million |
| Accounts payables | -773 Thousand | -25 Thousand | 274 Thousand | 54 Thousand | 199 Thousand | -3.7 Million |
| Inventory | - | - | -3.55 Million | 1.33 Million | 1.46 Million | 1.53 Million |
| Other working capital | -5.48 Million | -2.14 Million | 2.51 Million | 14.95 Million | 8.02 Million | -271 Thousand |
| Cash at beginning of period | 52.99 Million | 76.05 Million | 115.06 Million | 79.74 Million | 61.72 Million | 71.33 Million |
| Cash at end of period | 6.06 Million | 52.99 Million | 76.05 Million | 115.06 Million | 79.74 Million | 61.72 Million |
| Capital Expenditure | -197 Thousand | -216 Thousand | -3.32 Million | -9.77 Million | -284 Thousand | -459 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -46.93 Million | -23.05 Million | -39.01 Million | 35.32 Million | 18.01 Million | -9.6 Million |
| Free Cash Flow | -30.33 Million | -29.44 Million | -64.79 Million | -66.79 Million | -41.13 Million | -49.91 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.12 Million | -1.68 Million | -35.14 Million | -7.84 Million | -8.47 Million | -8.77 Million |
| Depreciation & Amortization | 1000.00 | 2000.00 | 2.31 Million | 241 Thousand | 679 Thousand | 699 Thousand |
| Deferred income taxes | - | - | 770 Thousand | -1.41 Million | 1.01 Million | 10 Thousand |
| Stock-based compensation | 102 Thousand | 172 Thousand | 2.8 Million | 250 Thousand | 726 Thousand | 914 Thousand |
| Change in working capital | -656 Thousand | -409 Thousand | -6.25 Million | -2.72 Million | -701 Thousand | -1.3 Million |
| Other non-cash items | 340 Thousand | 195 Thousand | 5.36 Million | 4.1 Million | 385 Thousand | 1.45 Million |
| Investing Cash Flow | - | - | 1.34 Million | 1.5 Million | 1000.00 | -135 Thousand |
| Investments in PPE | - | - | -197 Thousand | - | -1000.00 | -135 Thousand |
| Acquisitions | - | - | 1.54 Million | 1.5 Million | 2000.00 | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | 1.54 Million | 1.54 Million | - | - |
| Financing Cash Flow | - | - | -18.13 Million | - | - | -11.98 Million |
| Debt repayment | - | - | -18.1 Million | -125 Thousand | - | -11.85 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 92 Thousand | - | - | - |
| Other Financing Activities | - | - | -125 Thousand | -18.1 Million | - | -125 Thousand |
| Accounts receivables | -3000.00 | - | 3000.00 | -1000.00 | 4000.00 | -4000.00 |
| Accounts payables | -232 Thousand | -19 Thousand | -773 Thousand | -681 Thousand | -182 Thousand | 200 Thousand |
| Inventory | - | - | - | - | -4000.00 | 4000.00 |
| Other working capital | -421 Thousand | -390 Thousand | -5.48 Million | -2.03 Million | -519 Thousand | -1.5 Million |
| Cash at beginning of period | 4.14 Million | 6.06 Million | 52.99 Million | 11.94 Million | 18.31 Million | 37.43 Million |
| Cash at end of period | 2.46 Million | 4.14 Million | 6.06 Million | 6.06 Million | 11.94 Million | 18.31 Million |
| Capital Expenditure | - | - | -197 Thousand | - | -1000.00 | -135 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -1.68 Million | -1.91 Million | -46.93 Million | -5.88 Million | -6.37 Million | -19.11 Million |
| Free Cash Flow | -1.68 Million | -1.91 Million | -30.33 Million | -7.38 Million | -6.37 Million | -7.13 Million |
YBOX
CGBD
TMOAY
BEP-UN
TITAN
MTLHY